These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24258070)

  • 1. Toll-like receptor (TLR)-3: a potent driving force behind rheumatoid arthritis.
    Li X; Xu T; Wang Y; Huang C; Li J
    Clin Rheumatol; 2014 Feb; 33(2):291-2. PubMed ID: 24258070
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs.
    Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Sasaki K; Sasaki A; Ohki H; Takakubo N; Konttinen YT; Takagi M
    Clin Rheumatol; 2013 Jun; 32(6):853-61. PubMed ID: 23397147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor--a potent driving force behind rheumatoid arthritis.
    Takagi M
    J Clin Exp Hematop; 2011; 51(2):77-92. PubMed ID: 22104306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?
    McDonald S; Reed R; Baricevic-Jones I; ; Ling S; Plant D; Barton A
    Rheumatology (Oxford); 2019 Oct; 58(10):1872-1873. PubMed ID: 31329971
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting interleukin-33 in rheumatoid arthritis.
    Rong C; Hu W; Wu FR; Chen FH
    Rheumatol Int; 2013 May; 33(5):1377-8. PubMed ID: 22210269
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands.
    Pierer M; Rethage J; Seibl R; Lauener R; Brentano F; Wagner U; Hantzschel H; Michel BA; Gay RE; Gay S; Kyburz D
    J Immunol; 2004 Jan; 172(2):1256-65. PubMed ID: 14707104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF; Joosten LA; Abdollahi-Roodsaz S; van Lieshout AW; Sprong T; van den Hoogen FH; van den Berg WB; Radstake TR
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-17 increases the expression of Toll-like receptor 3 via the STAT3 pathway in rheumatoid arthritis fibroblast-like synoviocytes.
    Lee SY; Yoon BY; Kim JI; Heo YM; Woo YJ; Park SH; Kim HY; Kim SI; Cho ML
    Immunology; 2014 Mar; 141(3):353-61. PubMed ID: 24708416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adhesion molecule in pathogenesis of rheumatoid arthritis].
    Origuchi T; Eguchi K
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():200-7. PubMed ID: 15799346
    [No Abstract]   [Full Text] [Related]  

  • 11. Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
    Šenolt L; Prajzlerová K; Hulejová H; Šumová B; Filková M; Veigl D; Pavelka K; Vencovský J
    Cytokine; 2017 Sep; 97():187-192. PubMed ID: 28662439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response.
    Matsuyama Y; Okazaki H; Hoshino M; Onishi S; Kamata Y; Nagatani K; Nagashima T; Iwamoto M; Yoshio T; Ohto-Ozaki H; Tamemoto H; Komine M; Sekiya H; Tominaga S; Minota S
    Rheumatol Int; 2012 May; 32(5):1397-401. PubMed ID: 21431944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The use of ultrasound to assess the extent of inflammation in rheumatoid arthritis].
    Hammer HB
    Ultraschall Med; 2010 Aug; 31(4):437-8. PubMed ID: 20725899
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 2014 Dec; 56(1458):127-32. PubMed ID: 25519024
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic targets for rheumatoid arthritis.
    Keystone EC; Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():1. PubMed ID: 19509323
    [No Abstract]   [Full Text] [Related]  

  • 16. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
    Saag KG; Teng GG; Patkar NM; Anuntiyo J; Finney C; Curtis JR; Paulus HE; Mudano A; Pisu M; Elkins-Melton M; Outman R; Allison JJ; Suarez Almazor M; Bridges SL; Chatham WW; Hochberg M; MacLean C; Mikuls T; Moreland LW; O'Dell J; Turkiewicz AM; Furst DE;
    Arthritis Rheum; 2008 Jun; 59(6):762-84. PubMed ID: 18512708
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
    Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
    Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Toll-like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation.
    Kim SJ; Chen Z; Essani AB; Elshabrawy HA; Volin MV; Volkov S; Swedler W; Arami S; Sweiss N; Shahrara S
    Arthritis Rheumatol; 2016 May; 68(5):1099-110. PubMed ID: 26662519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis: New EULAR guidelines for RA: a job well done.
    Kremer JM
    Nat Rev Rheumatol; 2014 Jan; 10(1):6-8. PubMed ID: 24296679
    [No Abstract]   [Full Text] [Related]  

  • 20. SIGIRR/TIR-8 is an inhibitor of Toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis.
    Drexler SK; Kong P; Inglis J; Williams RO; Garlanda C; Mantovani A; Yazdi AS; Brennan F; Feldmann M; Foxwell BM
    Arthritis Rheum; 2010 Aug; 62(8):2249-61. PubMed ID: 20506350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.